Rubius Therapeutics to Present at the Jefferies Global Healthcare Conference
Rubius Therapeutics CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood...